| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654852 | 09569014 | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569014/09569014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569014/09569014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664336 | View Edit Delete | |||||||||||
| 654853 | 09569026 | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569026/09569026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569026/09569026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664337 | View Edit Delete | |||||||||||
| 654854 | 09569038 | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569038/09569038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569038/09569038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664338 | View Edit Delete | |||||||||||
| 655134 | 62024 | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 40 comprimidos | 75 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62024/62024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62024/62024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 657353 | 62206 | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (AL/PVC/PVDC) | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos (AL/PVC/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62206/62206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62206/62206_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 656376 | 68172 | GABAPENTINA TEVAGEN 300 mg CAPSULAS DURAS EFG | GABAPENTINA TEVAGEN 300 mg CAPSULAS DURAS EFG , 90 cápsulas | 300 mg | 5 | 90 | 43 | 90 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68172/68172_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68172/68172_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-11-20 | 1 | 1 | 1 | 2006-11-20 | 2006-11-20 | 0 | 2011-10-24 | View Edit Delete | ||||||||||||
| 656377 | 68173 | GABAPENTINA TEVAGEN 400 mg CAPSULAS DURAS EFG | GABAPENTINA TEVAGEN 400 mg CAPSULAS DURAS EFG , 90 cápsulas | 400 mg | 5 | 90 | 43 | 90 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68173/68173_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68173/68173_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2006-11-20 | 1 | 1 | 1 | 2006-11-20 | 2006-11-20 | 0 | 2011-10-24 | View Edit Delete | ||||||||||||
| 656531 | 66198 | GABAPENTINA TEVA-RATIOPHARM 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | GABAPENTINA TEVA-RATIOPHARM 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 90 comprimidos | 800 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66198/66198_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66198/66198_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-06-29 | 1 | 1 | 1 | 2004-06-29 | 2007-04-24 | 0 | 2011-10-07 | 742601 | View Edit Delete | |||||||||||
| 657023 | 63472 | TRAMADOL TEVA-RATIOPHARM 50 mg CAPSULAS DURAS EFG | TRAMADOL TEVA-RATIOPHARM 50 mg CAPSULAS DURAS EFG, 60 cápsulas | 50 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63472/63472_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63472/63472_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2000-11-22 | 1 | 1 | 1 | 2000-11-22 | 2000-11-22 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 658319 | 68373 | LORMETAZEPAM TEVA 1 mg COMPRIMIDOS EFG | LORMETAZEPAM TEVA 1 mg COMPRIMIDOS EFG, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68373/68373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68373/68373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-01-23 | 1 | 1 | 1 | 2007-01-23 | 2007-01-23 | 1 | 2011-10-24 | Lista IV | View Edit Delete | |||||||||||
| 658320 | 68374 | LORMETAZEPAM TEVA 2 mg COMPRIMIDOS EFG | LORMETAZEPAM TEVA 2 mg COMPRIMIDOS EFG , 20 comprimidos | 2 mg | 5 | 20 | 10 | 20 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68374/68374_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68374/68374_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-01-23 | 1 | 1 | 1 | 2007-01-23 | 2007-01-23 | 1 | 2011-10-24 | Lista IV | View Edit Delete | |||||||||||
| 658394 | 68425 | AMLODIPINO RATIOPHARM 5 mg COMPRIMIDOS EFG | AMLODIPINO RATIOPHARM 5 mg COMPRIMIDOS EFG , 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68425/68425_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68425/68425_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-01-30 | 1 | 1 | 1 | 2007-01-30 | 2007-01-30 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 658395 | 68426 | AMLODIPINO RATIOPHARM 10 mg COMPRIMIDOS EFG | AMLODIPINO RATIOPHARM 10 mg COMPRIMIDOS EFG , 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68426/68426_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68426/68426_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-01-30 | 1 | 1 | 1 | 2007-01-30 | 2007-01-30 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 656373 | 68169 | SERTRALINA TECNIGEN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TECNIGEN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68169/68169_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68169/68169_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2006-11-17 | 1 | 1 | 1 | 2006-11-17 | 2006-11-17 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 656374 | 68170 | SERTRALINA TECNIGEN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TECNIGEN 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 100 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68170/68170_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68170/68170_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2006-11-17 | 1 | 1 | 1 | 2006-11-17 | 2006-11-17 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 658341 | 68388 | RAMIPRIL/HIDROCLOROTIAZIDA TECNIGEN 2,5/12,5 mg COMPRIMIDOS EFG | RAMIPRIL/HIDROCLOROTIAZIDA TECNIGEN 2,5/12,5 mg COMPRIMIDOS EFG, 28 comprimidos | 2,5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68388/68388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68388/68388_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2007-01-31 | 1 | 1 | 1 | 2007-01-31 | 2007-01-31 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 658343 | 68389 | RAMIPRIL/HIDROCLOROTIAZIDA TECNIGEN 5/25 mgCOMPRIMIDOS EFG | RAMIPRIL/HIDROCLOROTIAZIDA TECNIGEN 5/25 mgCOMPRIMIDOS EFG, 28 comprimidos | 5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68389/68389_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68389/68389_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2007-01-31 | 1 | 1 | 1 | 2007-01-31 | 2007-01-31 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 654783 | 71125 | TARGIN 20 mg/10 mg COMPRIMIDOS DE LIBERACION PROLONGADA | TARGIN 20 mg/10 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 56 comprimidos | 20 mg/10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71125/71125_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71125/71125_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11860 | MUNDIPHARMA PHARMACEUTICALS S.L. | 2010-04-27 | 1 | 1 | 1 | 2010-04-27 | 2013-07-08 | 1 | 2014-01-02 | 667963 | Lista I | View Edit Delete | ||||||||||
| 656295 | 68132 | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68132/68132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68132/68132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2006-11-03 | 1 | 1 | 1 | 2006-11-03 | 2006-11-03 | 1 | 2018-06-19 | View Edit Delete | ||||||||||||
| 656296 | 68132 | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68132/68132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68132/68132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2006-11-03 | 1 | 1 | 1 | 2006-11-03 | 2006-11-03 | 1 | 2018-06-19 | View Edit Delete |
Page 123 of 1035, showing 20 records out of 20684 total, starting on record 2441, ending on 2460